id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_wn6awlddpbeztpigfwaxuan4au	B Jonsson	PMS40 UTILITY AND QUALITY OF LIFE OF PATIENTS WITH OSTEOARTHRITIS TREATED WITH THE CYCLOOXYGENASE INHIBITING NITRIC OXIDE DONATOR (CINOD) NAPROXCINOD	2009	1	.pdf	application/pdf	1811	136	60	PMS40 UTILITY AND QUALITY OF LIFE OF PATIENTS WITH OSTEOARTHRITIS TREATED WITH THE CYCLOOXYGENASE INHIBITING NITRIC OXIDE DONATOR (CINOD) NAPROXCINOD The Health Assessment Questionnaire (HAQ) was used to measure functional status (scores 0–3). reported signifi cantly worse scores in morning stiffness, fatigue, pain, and PCS (all CONCLUSIONS: RA patients using current SC biologics still suffer from serious impairments in symptoms, functional status, QoL, and However, patients who discontinued SC biologic therapy have signifi cantly worse symptom scores, physical functioning, and activity impairment compared with those currently being treated. Utility scores correlated signifi cantly with WOMAC™, and patients with high BMI RESULTS: Compared to the general population, our study sample performed poorly with respect to all the SF-36 domains except mental health (MH) and patients who exercise regularly have higher quality of life scores and clinical outcomes. validity of the HUI-3 for deriving utility scores for AS patients.	./cache/work_wn6awlddpbeztpigfwaxuan4au.pdf	./txt/work_wn6awlddpbeztpigfwaxuan4au.txt